Toby B Lanser

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Chronic Rhinosinusitis

Regulatory T Cells

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Thais G Moreira, Christian D Gauthier, Liam Murphy, Toby B Lanser, Anu Paul, Kimble T F Matos, Davide Mangani, Saef Izzy, Rafael Machado Rezende, Brian C Healy, Clare M Baecher-Allan, Tanuja Chitinis, Vijay Kuchroo, Howard L Weiner
Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19. Proceedings of the National Academy of Sciences of the United States of America 120 (11) (2023)
Thais G Moreira, Christian D Gauthier, Liam Murphy, Toby B Lanser, Anu Paul, Kimble T F Matos, Davide Mangani, Saef Izzy, Rafael Machado Rezende, Brian C Healy, Clare M Baecher-Allan, Tanuja Chitinis, Vijay Kuchroo, Howard L Weiner
Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19. Proceedings of the National Academy of Sciences of the United States of America 120 (11) (2023)
Juliana R Lopes, Xiaoming Zhang, Julia Mayrink, Bruna K Tatematsu, Lydia Guo, Danielle S LeServe, Hadi Abou-El-Hassan, Felipe Rong, Maria J Dalton, Marilia G Oliveira, Toby B Lanser, Lei Liu, Oleg Butovsky, Rafael Machado Rezende, Howard L Weiner
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 120 (37) (2023)
Thais G Moreira, Christian D Gauthier, Liam Murphy, Toby B Lanser, Anu Paul, Kimble T F Matos, Davide Mangani, Saef Izzy, Rafael Machado Rezende, Brian C Healy, Clare M Baecher-Allan, Tanuja Chitinis, Vijay Kuchroo, Howard L Weiner
Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19. Proceedings of the National Academy of Sciences of the United States of America 120 (11) (2023)
Thais G Moreira, Christian D Gauthier, Liam Murphy, Toby B Lanser, Anu Paul, Kimble T F Matos, Davide Mangani, Saef Izzy, Rafael Machado Rezende, Brian C Healy, Clare M Baecher-Allan, Tanuja Chitinis, Vijay Kuchroo, Howard L Weiner
Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19. Proceedings of the National Academy of Sciences of the United States of America 120 (11) (2023)